1-3 of 3
David E. Kleiner
Close
Sort by
Journal Articles

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell–depleted stem cell transplantation

Clinical Trials & Observations
Nirali N. Shah, Kristin Baird, Cynthia P. Delbrook, Thomas A. Fleisher, Mark E. Kohler, Shakuntala Rampertaap, Kimberly Lemberg, Carolyn K. Hurley, David E. Kleiner, Melinda S. Merchant, Stefania Pittaluga, Marianna Sabatino, David F. Stroncek, Alan S. Wayne, Hua Zhang, Terry J. Fry, Crystal L. Mackall
Journal: Blood
Blood (2015) 125 (5): 784–792.
https://doi.org/10.1182/blood-2014-07-592881
Published: 2015
Journal Articles

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

Thomas A. Waldmann, Enrico Lugli, Mario Roederer, Liyanage P. Perera, Jeremy V. Smedley, Rhonda P. Macallister, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Thomas A. Fleisher, H. Clifford Lane, Michael C. Sneller, Roger J. Kurlander, David E. Kleiner, John M. Pletcher, William D. Figg, Jason L. Yovandich, Stephen P. Creekmore
Journal: Blood
Blood (2011) 117 (18): 4787–4795.
https://doi.org/10.1182/blood-2010-10-311456
Published: 2011
Includes: Supplemental data
Journal Articles

Peripheral CD4 + CD8 + T cells are differentiated effector memory cells with antiviral functions

Michelina Nascimbeni, Eui-Cheol Shin, Luis Chiriboga, David E. Kleiner, Barbara Rehermann
Journal: Blood
Blood (2004) 104 (2): 478–486.
https://doi.org/10.1182/blood-2003-12-4395
Published: 2004